查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1947485

病患登記軟體市場：依類型、交付模式、功能、資料庫、定價模式和最終用戶劃分 - 全球預測至 2036 年

Patient Registry Software Market by Type, Delivery, Functionality, Database, Pricing Model, End User - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 262 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球病患登記軟體市場預計將以 10.5% 的複合年增長率成長，從 2026 年的 20.4 億美元成長到 2036 年的約 55.2 億美元。

本報告對全球五大主要區域的患者登記軟體市場進行了詳細分析，重點關注當前市場趨勢、市場規模、近期發展以及至 2036 年的預測。透過廣泛的二級和一級研究以及對市場現狀的深入分析，我們對關鍵產業驅動因素、限制因素、機會和挑戰進行了影響分析。

推動病患登記軟體市場成長的關鍵因素包括：電子健康記錄 (EHR) 的日益普及、提高醫療品質和降低醫療成本的壓力不斷增加、病患登記資料在上市後監測中的應用日益廣泛以及雲端解決方案的擴展。 此外，對人口健康管理舉措的日益重視、人工智慧與真實世界證據的融合以及以患者為主導的研究網絡的發展，預計將為在患者登記軟體市場運營的公司創造巨大的增長機會。

市場區隔

目錄

第一章：引言

第二章：研究方法

第三章：摘要整理

第四章：市場洞察

  • 市場動態
    • 驅動因素
      • 電子健康記錄 (EHR) 的日益普及
      • 提高醫療品質的壓力日益增大
      • 上市後監測中病患資料的使用日益增多
      • 人口健康管理計畫的擴展
    • 限制因素
      • 資料隱私與安全問題
      • 實施難度高成本
    • 機遇
      • 基於雲端的解決方案和以患者為中心的研究網絡
      • 真實世界數據 (RWE) 與人工智慧的整合
      • 新興的個人化醫療應用
      • 罕見疾病登記庫的擴展
  • 價值鏈分析

第五章 全球病患登記軟體市場（依登記類型劃分）

  • 疾病登記庫
    • 慢性病登記庫
    • 罕見疾病登記庫
    • 腫瘤登記庫
  • 藥物登記庫
    • 上市後監測登記庫
    • 藥物警戒登記庫
  • 醫療器材登記庫
    • 植入物註冊庫
    • 診斷設備註冊庫
  • 其他註冊庫類型

第六章：全球病患註冊庫軟體市場（依軟體類型劃分）

  • 本地部署解決方案
  • 雲端解決方案
  • 混合解決方案

第七章：全球病患註冊庫軟體市場（依定價模式劃分）

  • 訂閱定價
  • 永久許可
  • 以使用量定價
  • 混合定價模式

第八章：全球病患註冊庫軟體市場（依資料庫類型劃分）

  • 公共註冊庫
  • 商業註冊庫
  • 學術和機構註冊庫

章節第九章：全球病患登記軟體市場依功能劃分

  • 人群健康管理 (PHM)
  • 健康資訊交換 (HIE) 整合
  • 床邊臨床決策支援 (POC)
  • 調查與真實世界證據分析
  • 報告和監管合規

第十章：全球病患登記軟體市場依最終使用者劃分

  • 醫院和醫療機構
  • 製藥公司
  • 醫療器材製造商
  • 研究機構
  • 政府機構
  • 其他最終用戶

第十一章：全球病患登記軟體市場依地區劃分

  • 北美
    • 美國美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第十二章 競爭格局

  • 主要成長策略
  • 競爭標竿分析
  • 市佔率分析

第11章 企業簡介

  • SPX FLOW, Inc.
  • EIRICH Machines GmbH
  • Silverson Machines Ltd.
  • Hosokawa Micron B.V.
  • GMM Pfaudler Ltd.
  • Charles Ross &Son Company
  • Readco Kurimoto, LLC
  • Marion Process Solutions
  • Palamatic Process Inc.
  • EKATO Holding GmbH
  • NETZSCH Group
  • Bachiller Group
  • INOXPA S.A.U.
  • MixMor(NOV Inc.)
  • Others

第12章 附錄

簡介目錄
Product Code: MRHC - 10413

Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2036

According to the research report titled, 'Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2036,' the global patient registry software market is expected to reach approximately USD 5.52 billion by 2036 from USD 2.04 billion in 2026, at a CAGR of 10.5% during the forecast period (2026-2036).

The report provides an in-depth analysis of the global patient registry software market across five major regions, emphasizing the current market trends, market sizes, recent developments, and forecasts till 2036. Following extensive secondary and primary research and an in-depth analysis of the market scenario, the report conducts the impact analysis of the key industry drivers, restraints, opportunities, and challenges.

The major factors driving the growth of the patient registry software market include the increasing adoption of electronic health records (EHRs), rising pressure to improve quality of care and reduce healthcare costs, growing use of patient registry data for post-marketing surveillance, and expansion of cloud-based solutions. Additionally, the growing emphasis on population health management initiatives, integration of artificial intelligence and real-world evidence, and development of patient-powered research networks are expected to create significant growth opportunities for players operating in the patient registry software market.

Market Segmentation

The patient registry software market is segmented by type (diabetes, cancer, rare diseases, CVD, orthopedic, drugs, device), delivery model (on-premise, cloud), functionality (population health management, health information exchange, point of care, research), database type (public, commercial), pricing model, end-user (hospitals, medical practices, pharmaceutical companies, medical device manufacturers), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Registry Type

By registry type, disease registries dominate the market, accounting for the largest revenue share in 2026. Disease registries are driven by the increasing prevalence of chronic diseases and the growing need for data to support clinical research and public health initiatives. The development of new and advanced disease registries for conditions including cardiovascular diseases, diabetes, cancer, and rare diseases has accelerated market adoption. Disease registries enable healthcare organizations to track patient outcomes, monitor treatment effectiveness, and identify best practices for disease management. Drug and device registries represent the fastest-growing registry type segments, driven by the proliferation of new pharmaceutical products and medical devices, regulatory requirements for post-market surveillance, and expansion of real-world evidence initiatives.

Based on Delivery Model

By delivery model, cloud-based solutions are projected to witness the fastest growth among software types through 2036. Cloud-based platforms offer greater flexibility, scalability, and accessibility compared to on-premise solutions, enabling healthcare organizations to reduce infrastructure costs while improving data accessibility across multiple locations. The emergence of patient-powered research networks (PPRNs) is driving significant innovation in cloud-based solutions. On-premise solutions continue to serve healthcare organizations with specific data security and regulatory compliance requirements, maintaining a significant market share.

Based on Functionality

By functionality, population health management is expected to be the largest functionality segment in 2026. Population health management capabilities enable healthcare organizations to monitor and improve health outcomes across patient populations. Health information exchange (HIE) functionality facilitates seamless data sharing across healthcare systems. Point of care (POC) functionality supports clinical decision-making at the patient encounter level. Research functionality enables clinical research and epidemiological studies, with growing emphasis on real-world evidence collection and analysis.

Based on End-User

By end-user, hospitals and medical practices are projected to be the dominant end-user segment in 2026, driven by the increasing adoption of EHRs and growing emphasis on quality improvement initiatives. Healthcare organizations are utilizing patient registry software to track patient outcomes, monitor treatment effectiveness, and support clinical decision-making. Pharmaceutical and medical device manufacturers are expanding their use of patient registry software for post-marketing surveillance, real-world evidence collection, and regulatory compliance. The increasing regulatory requirements for post-market surveillance are driving adoption of specialized registry solutions among pharmaceutical and device companies.

Geographic Analysis

An in-depth geographic analysis of the industry provides detailed qualitative and quantitative insights into the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) and the coverage of major countries in each region. North America is expected to hold the largest market share in 2026, driven by advanced healthcare infrastructure, high adoption of EHRs, and strong regulatory framework for data management. Europe and Asia-Pacific are projected to experience steady growth from 2026 to 2036, driven by adoption of advanced healthcare technologies and increasing focus on population health management. Latin America and the Middle East & Africa are emerging markets with growing demand for patient registry software.

Key Players

The key players operating in the global patient registry software market are Phytel, Inc. (IBM Corporation), Quintiles IMS Holdings, Inc., McKesson Corporation, Medidata Solutions, Veradigm LLC, Inovalon Holdings, Inc., Health Catalyst, Inc., Optum, Inc., Allscripts Healthcare Solutions, and Cerner Corporation, among others.

Key Questions Answered in the Report

  • What is the current revenue generated by the patient registry software market globally?
  • At what rate is the global patient registry software market demand projected to grow for the next 7-10 years?
  • What are the historical market sizes and growth rates of the global patient registry software market?
  • What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of registry type, delivery model, functionality, and end-user are expected to create major traction for the service providers in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the global patient registry software market?
  • Who are the major players in the global patient registry software market? What are their specific service offerings in this market?
  • What are the recent strategic developments in the global patient registry software market? What are the impacts of these strategic developments on the market?

Scope of the Report:

Patient Registry Software Market Assessment -- by Registry Type

  • Diabetes
  • Cancer
  • Rare Diseases
  • Cardiovascular Diseases (CVD)
  • Orthopedic
  • Drug Registries
  • Device Registries

Patient Registry Software Market Assessment -- by Delivery Model

  • On-Premise
  • Cloud-Based

Patient Registry Software Market Assessment -- by Functionality

  • Population Health Management (PHM)
  • Health Information Exchange (HIE)
  • Point of Care (POC)
  • Research

Patient Registry Software Market Assessment -- by Database Type

  • Public
  • Commercial

Patient Registry Software Market Assessment -- by End-User

  • Hospitals and Medical Practices
  • Pharmaceutical Manufacturers
  • Medical Device Manufacturers
  • Healthcare Payers
  • Government and Public Health Agencies

Patient Registry Software Market Assessment -- by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency & Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Process
  • 2.2 Data Collection & Validation
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research
  • 2.3 Market Assessment
    • 2.3.1 Market Size Estimation
    • 2.3.2 Bottom-Up Approach
    • 2.3.3 Top-Down Approach
    • 2.3.4 Growth Forecast
  • 2.4 Assumptions for the Study
  • 2.5 Limitations for the Study

3. Executive Summary

4. Market Insights

  • 4.1 Introduction
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
      • 4.2.1.1 Rising Adoption of Electronic Health Records (EHRs)
      • 4.2.1.2 Increasing Pressure to Improve Quality of Care
      • 4.2.1.3 Growing Use of Patient Data for Post-Marketing Surveillance
      • 4.2.1.4 Expansion of Population Health Management Programs
    • 4.2.2 Restraints
      • 4.2.2.1 Data Privacy and Security Concerns
      • 4.2.2.2 High Implementation Costs
    • 4.2.3 Opportunities
      • 4.2.3.1 Cloud-Based Solutions and Patient-Powered Research Networks
      • 4.2.3.2 Integration of Real-World Evidence (RWE) and AI
      • 4.2.3.3 Emerging Personalized Medicine Applications
      • 4.2.3.4 Expansion of Rare Disease Registries
  • 4.3 Value Chain Analysis

5. Global Patient Registry Software Market, by Registry Type

  • 5.1 Introduction
  • 5.2 Disease Registries
    • 5.2.1 Chronic Disease Registries
    • 5.2.2 Rare Disease Registries
    • 5.2.3 Oncology Registries
  • 5.3 Drug Registries
    • 5.3.1 Post-Marketing Surveillance Registries
    • 5.3.2 Pharmacovigilance Registries
  • 5.4 Device Registries
    • 5.4.1 Implant Registries
    • 5.4.2 Diagnostic Device Registries
  • 5.5 Other Registry Types

6. Global Patient Registry Software Market, by Software Type

  • 6.1 Introduction
  • 6.2 On-Premise Solutions
  • 6.3 Cloud-Based Solutions
  • 6.4 Hybrid Solutions

7. Global Patient Registry Software Market, by Pricing Model

  • 7.1 Introduction
  • 7.2 Subscription-Based Pricing
  • 7.3 Perpetual License
  • 7.4 Usage-Based Pricing
  • 7.5 Hybrid Pricing Model

8. Global Patient Registry Software Market, by Database Type

  • 8.1 Introduction
  • 8.2 Public Registries
  • 8.3 Commercial Registries
  • 8.4 Academic & Institutional Registries

9. Global Patient Registry Software Market, by Functionality

  • 9.1 Introduction
  • 9.2 Population Health Management (PHM)
  • 9.3 Health Information Exchange (HIE) Integration
  • 9.4 Point-of-Care (POC) Clinical Decision Support
  • 9.5 Research & Real-World Evidence Analytics
  • 9.6 Reporting & Regulatory Compliance

10. Global Patient Registry Software Market, by End User

  • 10.1 Introduction
  • 10.2 Hospitals and Medical Practices
  • 10.3 Pharmaceutical Companies
  • 10.4 Medical Device Manufacturers
  • 10.5 Research Institutions
  • 10.6 Government Agencies
  • 10.7 Other End Users

11. Global Patient Registry Software Market, by Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 U.K.
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Russia
    • 11.3.7 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Australia
    • 11.4.6 Rest of Asia-Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 Rest of Middle East & Africa

12. Competitive Landscape

  • 12.1 Introduction
  • 12.2 Key Growth Strategies
  • 12.3 Competitive Benchmarking
  • 12.4 Market Share Analysis

13. Company Profiles

  • 13.1 Phytel, Inc. (IBM Corporation)
  • 13.2 IQVIA Holdings Inc.
  • 13.3 McKesson Corporation
  • 13.4 Medidata Solutions
  • 13.5 Veradigm LLC
  • 13.6 Inovalon Holdings, Inc.
  • 13.7 Health Catalyst, Inc.
  • 13.8 Optum, Inc.
  • 13.9 Allscripts Healthcare Solutions
  • 13.10 Oracle Cerner
  • 13.11 Others

14. Appendix

  • 14.1 Questionnaire
  • 14.2 Available Customization